289PSafety and efficacy of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma from China. (25th November 2018) - Song, Y; Hong, X; Huang, H; Bai, B; Zhang, H; Ke, X; Shi, Y; Zhu, J; Lu, G; Liebscher, S; Cai, C